Publicações

Pharmacogenetic Determinants of Outcomes on Triplet Hepatic Artery Infusion and Intravenous Cetuximab for Liver Metastases from Colorectal Cancer (European Trial Optiliv, Nct00852228)

AuthID
P-00N-27B

Author(s)

Levi, F

Karaboue, A

Saffroy, R

Desterke, C

Boige, V

Smith, D

Hebbar, M

Innominato, P

Taieb, J

Carvalho, C

Guimbaud, R

Focan, C

Bouchahda, M

Adam, R

Ducreux, M

Milano, G

Lemoine, A

Group Author(s)

ARTBC Int

Document Type

Article

Year published

2017

Published

in BRITISH JOURNAL OF CANCER, ISSN: 0007-0920

Volume: 117, Issue: 7, Pages: 965-973 (9)

Indexing

Wos^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1038/bjc.2017.278

Wos: WOS:000411710900008

Source Identifiers

ISSN: 0007-0920

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Pharmacogenetic Determinants of Outcomes on Triplet Hepatic Artery Infusion and Intravenous Cetuximab for Liver Metastases from Colorectal Cancer (European Trial Optiliv, Nct00852228)

Useful Links

Get Help

Autenticação Federada (Click on the image)

Pharmacogenetic Determinants of Outcomes on Triplet Hepatic Artery Infusion and Intravenous Cetuximab for Liver Metastases from Colorectal Cancer (European Trial Optiliv, Nct00852228)

Useful Links

Get Help